Understanding the Pathogenesis of Recessive Dystrophic Epidermolysis Bullosa Squamous Cell Carcinoma

Dermatologic Clinics

Volumn 28, Issue 1, 2010, Pages 171-178

  South, Andrew P ^a   O'Toole, Edel A ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cancer; COL7A1; Epidermolysis bullosa; Metastasis; Type VII collagen

Indexed keywords

COLLAGEN; COLLAGEN TYPE 7 ALPHA1; UNCLASSIFIED DRUG;

CANCER RISK; CARCINOGENESIS; EPIDERMOLYSIS BULLOSA DYSTROPHICA; GENE MUTATION; GENETIC ASSOCIATION; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; MUTATIONAL ANALYSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SKIN CARCINOMA; SKIN SCAR; SKIN ULCER; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; COLLAGEN TYPE VII; EPIDERMOLYSIS BULLOSA DYSTROPHICA; HUMANS; SKIN NEOPLASMS;

EID: 70450267630     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2009.10.023     Document Type: Review

References (75)

1. Reed W.B., College Jr. J., Francis M.J., et al. Epidermolysis bullosa dystrophica with epidermal neoplasms. Arch Dermatol 110 6 (1974) 894-902
2. Fine J.D., Johnson L.B., Weiner M., et al. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006. J Am Acad Dermatol 60 2 (2009) 203-211
3. Daya-Grosjean L., and Sarasin A. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors. Mutat Res 571 1-2 (2005) 43-56
4. Brantsch K.D., Meisner C., Schonfisch B., et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 9 8 (2008) 713-720
5. Veness M.J., Porceddu S., Palme C.E., et al. Cutaneous head and neck squamous cell carcinoma metastatic to parotid and cervical lymph nodes. Head Neck 29 7 (2007) 621-631
6. Varki R., Sadowski S., Uitto J., et al. Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes. J Med Genet 44 3 (2007) 181-192
7. McGrath J.A., Schofield O.M., Mayou B.J., et al. Epidermolysis bullosa complicated by squamous cell carcinoma: report of 10 cases. J Cutan Pathol 19 2 (1992) 116-123
8. Song I.C., and Dicksheet S. Management of squamous cell carcinoma in a patient with dominant-type epidermolysis bullosa dystrophica: a surgical challenge. Plast Reconstr Surg 75 5 (1985) 732-736
9. Christiano A.M., Crollick J., Pincus S., et al. Squamous cell carcinoma in a family with dominant dystrophic epidermolysis bullosa: a molecular genetic study. Exp Dermatol 8 2 (1999) 146-152
10. Chorny J.A., Shroyer K.R., and Golitz L.E. Malignant melanoma and a squamous cell carcinoma in recessive dystrophic epidermolysis bullosa. Arch Dermatol 129 9 (1993) 1212
11. Mallipeddi R. Epidermolysis bullosa and cancer. Clin Exp Dermatol 27 8 (2002) 616-623
12. McGrath J.A., Ishida-Yamamoto A., O'Grady A., et al. Structural variations in anchoring fibrils in dystrophic epidermolysis bullosa: correlation with type VII collagen expression. J Invest Dermatol 100 4 (1993) 366-372
13. Ogawa B., Chen M., Margolis J., et al. Marjolin's ulcer arising at the elbow: a case report and literature review. Hand (NY) 1 2 (2006) 89-93
14. Kowal-Vern A., and Criswell B.K. Burn scar neoplasms: a literature review and statistical analysis. Burns 31 4 (2005) 403-413
15. Kaplan R.P. Cancer complicating chronic ulcerative and scarifying mucocutaneous disorders. Adv Dermatol 2 (1987) 19-46
16. Brown V.L., Farrant P.B., Turner R.J., et al. Multiple aggressive squamous skin cancers in association with nonbullous congenital ichthyosiform erythroderma. Br J Dermatol 158 5 (2008) 1125-1128
17. Alexandrescu D.T., Dasanu C.A., Farzanmehr H., et al. Development of squamous cell carcinomas in Darier disease: a new model for skin carcinogenesis?. Br J Dermatol 159 6 (2008) 1378-1380
18. Hamm H., Traupe H., Brocker E.B., et al. The scleroatrophic syndrome of Huriez: a cancer-prone genodermatosis. Br J Dermatol 134 3 (1996) 512-518
19. Madariaga J., Fromowitz F., Phillips M., et al. Squamous cell carcinoma in congenital ichthyosis with deafness and keratitis. A case report and review of the literature. Cancer 57 10 (1986) 2026-2029
20. Lai-Cheong J.E., Tanaka A., Hawche G., et al. Kindler syndrome: a focal adhesion genodermatosis. Br J Dermatol 160 2 (2009) 233-242
21. Lotem M., Raben M., Zeltser R., et al. Kindler syndrome complicated by squamous cell carcinoma of the hard palate: successful treatment with high-dose radiation therapy and granulocyte-macrophage colony-stimulating factor. Br J Dermatol 144 6 (2001) 1284-1286
22. Emanuel P.O., Rudikoff D., and Phelps R.G. Aggressive squamous cell carcinoma in Kindler syndrome. Skinmed 5 6 (2006) 305-307
23. Goldberg G.I., Eisen A.Z., and Bauer E.A. Tissue stress and tumor promotion. Possible relevance to epidermolysis bullosa. Arch Dermatol 124 5 (1988) 737-741
24. Smoller B.A., McNutt N.S., Carter D.M., et al. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis. Arch Dermatol 126 1 (1990) 78-83
25. Tyring S.K., Chopra V., Johnson L., et al. Natural killer cell activity is reduced in patients with severe forms of inherited epidermolysis bullosa. Arch Dermatol 125 6 (1989) 797-800
26. Arbiser J.L., Fine J.D., Murrell D., et al. Basic fibroblast growth factor: a missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa. Mol Med 4 3 (1998) 191-195
27. Mott J.D., and Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16 5 (2004) 558-564
28. Bruckner-Tuderman L., Winberg J.O., Anton-Lamprecht I., et al. Anchoring fibrils, collagen VII, and neutral metalloproteases in recessive dystrophic epidermolysis bullosa inversa. J Invest Dermatol 99 5 (1992) 550-558
29. Bodemer C., Tchen S.I., Ghomrasseni S., et al. Skin expression of metalloproteinases and tissue inhibitor of metalloproteinases in sibling patients with recessive dystrophic epidermolysis and intrafamilial phenotypic variation. J Invest Dermatol 121 2 (2003) 273-279
30. Titeux M., Pendaries V., Tonasso L., et al. A frequent functional SNP in the MMP1 promoter is associated with higher disease severity in recessive dystrophic epidermolysis bullosa. Hum Mutat 29 2 (2008) 267-276
31. Kivisaari A.K., Kallajoki M., Mirtti T., et al. Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas. Br J Dermatol 158 4 (2008) 778-785
32. Cooper H.L., Cook I.S., Theaker J.M., et al. Expression and glycosylation of MUC1 in epidermolysis bullosa-associated and sporadic cutaneous squamous cell carcinomas. Br J Dermatol 151 3 (2004) 540-545
33. Mallipeddi R., Wessagowit V., South A.P., et al. Reduced expression of insulin-like growth factor-binding protein-3 (IGFBP-3) in squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa. J Invest Dermatol 122 5 (2004) 1302-1309
34. Sakai L.Y., Keene D.R., Morris N.P., et al. Type VII collagen is a major structural component of anchoring fibrils. J Cell Biol 103 4 (1986) 1577-1586
35. Leigh I.M., Eady R.A., Heagerty A.H., et al. Type VII collagen is a normal component of epidermal basement membrane, which shows altered expression in recessive dystrophic epidermolysis bullosa. J Invest Dermatol 90 5 (1988) 639-642
36. Wetzels R.H., Robben H.C., Leigh I.M., et al. Distribution patterns of type VII collagen in normal and malignant human tissues. Am J Pathol 139 2 (1991) 451-459
37. Wetzels R.H., van der Velden L.A., Schaafsma H.E., et al. Immunohistochemical localization of basement membrane type VII collagen and laminin in neoplasms of the head and neck. Histopathology 21 5 (1992) 459-464
38. Kainulainen T., Grenman R., Oikarinen A., et al. Distribution and synthesis of type VII collagen in oral squamous cell carcinoma. J Oral Pathol Med 26 9 (1997) 414-418
39. Visser R., Arends J.W., Leigh I.M., et al. Patterns and composition of basement membranes in colon adenomas and adenocarcinomas. J Pathol 170 3 (1993) 285-290
40. Tani T., Karttunen T., Kiviluoto T., et al. Alpha 6 beta 4 integrin and newly deposited laminin-1 and laminin-5 form the adhesion mechanism of gastric carcinoma. Continuous expression of laminins but not that of collagen VII is preserved in invasive parts of the carcinomas: implications for acquisition of the invading phenotype. Am J Pathol 149 3 (1996) 781-793
41. Paulus W., Baur I., Liszka U., et al. Expression of type VII collagen, the major anchoring fibril component, in normal and neoplastic human nervous system. Virchows Arch 426 2 (1995) 199-202
42. Lohi J., Leivo I., Owaribe K., et al. Neoexpression of the epithelial adhesion complex antigens in thyroid tumours is associated with proliferation and squamous differentiation markers. J Pathol 184 2 (1998) 191-196
43. Nagle R.B., Knox J.D., Wolf C., et al. Adhesion molecules, extracellular matrix, and proteases in prostate carcinoma. J Cell Biochem Suppl 19 (1994) 232-237
44. Bonkhoff H. Analytical molecular pathology of epithelial-stromal interactions in the normal and neoplastic prostate. Anal Quant Cytol Histol 20 5 (1998) 437-442
45. Hurst R., Elliott R.M., Goldson A.J., et al. Se-methylselenocysteine alters collagen gene and protein expression in human prostate cells. Cancer Lett 269 1 (2008) 117-126
46. Dumas V., Kanitakis J., Charvat S., et al. Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas. Anticancer Res 19 4B (1999) 2929-2938
47. Bechetoille N., Haftek M., Staquet M.J., et al. Penetration of human metastatic melanoma cells through an authentic dermal-epidermal junction is associated with dissolution of native collagen types IV and VII. Melanoma Res 10 5 (2000) 427-434
48. Kirkham N., Price M.L., Gibson B., et al. Type VII collagen antibody LH 7.2 identifies basement membrane characteristics of thin malignant melanomas. J Pathol 157 3 (1989) 243-247
49. Baba Y., Iyama K., Honda S., et al. Cytoplasmic expression of type VII collagen is related to prognosis in patients with esophageal squamous cell carcinoma. Oncology 71 3-4 (2006) 221-228
50. Kita Y., Mimori K., Tanaka F., et al. Clinical significance of LAMB3 and COL7A1 mRNA in esophageal squamous cell carcinoma. Eur J Surg Oncol 35 1 (2009) 52-58
51. Skovbjerg H., Anthonsen D., Lothe I.M., et al. Collagen mRNA levels changes during colorectal cancer carcinogenesis. BMC Cancer 9 (2009) 136
52. Chan T.A., Glockner S., Yi J.M., et al. Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis. PLoS Med 5 5 (2008) e114
53. Kanitakis J., Barthelemy H., Faure M., et al. Intracellular expression of type VII collagen in squamous cell carcinoma complicating dystrophic epidermolysis bullosa. Br J Dermatol 137 2 (1997) 310-313
54. McGrath J.A., Leigh I.M., and Eady R.A. Intracellular expression of type VII collagen during wound healing in severe recessive dystrophic epidermolysis bullosa and normal human skin. Br J Dermatol 127 4 (1992) 312-317
55. Boukamp P. Non-melanoma skin cancer: what drives tumor development and progression?. Carcinogenesis 26 10 (2005) 1657-1667
56. Dajee M., Lazarov M., Zhang J.Y., et al. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421 6923 (2003) 639-643
57. Balmain A., Ramsden M., Bowden G.T., et al. Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature 307 5952 (1984) 658-660
58. Daya-Grosjean L., Robert C., Drougard C., et al. High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients. Cancer Res 53 7 (1993) 1625-1629
59. Sato M., Nishigori C., Lu Y., et al. Far less frequent mutations in ras genes than in the p53 gene in skin tumors of xeroderma pigmentosum patients. Mol Carcinog 11 2 (1994) 98-105
60. Corominas M., Kamino H., Leon J., et al. Oncogene activation in human benign tumors of the skin (keratoacanthomas): is HRAS involved in differentiation as well as proliferation?. Proc Natl Acad Sci U S A 86 16 (1989) 6372-6376
61. Ananthaswamy H.N., Price J.E., Goldberg L.H., et al. Detection and identification of activated oncogenes in human skin cancers occurring on sun-exposed body sites. Cancer Res 48 12 (1988) 3341-3346
62. Pourreyron C., Cox G., Mao X., et al. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression. J Invest Dermatol 127 10 (2007) 2438-2444
63. Green C.L., and Khavari P.A. Targets for molecular therapy of skin cancer. Semin Cancer Biol 14 1 (2004) 63-69
64. Purdie K.J., Harwood C.A., Gulati A., et al. Single nucleotide polymorphism array analysis defines a specific genetic fingerprint for well-differentiated cutaneous SCCs. J Invest Dermatol 129 6 (2009) 1562-1568
65. Arbiser J.L., Fan C.Y., Su X., et al. Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma. J Invest Dermatol 123 4 (2004) 788-790
66. Heinonen S., Mannikko M., Klement J.F., et al. Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa. J Cell Sci 112 Pt 21 (1999) 3641-3648
67. Fritsch A., Loeckermann S., Kern J.S., et al. A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J Clin Invest 118 5 (2008) 1669-1679
68. Chen M., Kasahara N., Keene D.R., et al. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Nat Genet 32 4 (2002) 670-675
69. Woodley D.T., Remington J., Huang Y., et al. Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing. Mol Ther 15 3 (2007) 628-635
70. Chen M., Hou Y., Wang X., et al. A 684 helical domain of type VII collagen promotes in vivo skin wound closure by enhancing fibroblast and keratinocyte migration. J Invest Dermatol 128 (2008) S48
71. Ortiz-Urda S., Garcia J., Green C.L., et al. Type VII collagen is required for Ras-driven human epidermal tumorigenesis. Science 307 5716 (2005) 1773-1776
72. Tran M., Rousselle P., Nokelainen P., et al. Targeting a tumor-specific laminin domain critical for human carcinogenesis. Cancer Res 68 8 (2008) 2885-2894
73. Rodeck U., and Uitto J. Recessive dystrophic epidermolysis bullosa-associated squamous-cell carcinoma: an enigmatic entity with complex pathogenesis. J Invest Dermatol 127 10 (2007) 2295-2296
74. Martins V.L., Vyas J.J., Chen M., et al. Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen. J Cell Sci 122 Pt 11 (2009) 1788-1799
75. Guasch G., Schober M., Pasolli H.A., et al. Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia. Cancer Cell 12 4 (2007) 313-327